Quadrant Capital Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $661K | Buy |
2,372
+64
| +3% | +$18.4K | 0.02% | 769 |
|
|
2025
Q4 | $699K | Hold |
2,308
| – | – | 0.02% | 748 |
|
|
2025
Q3 | $647K | Buy |
2,308
+13
| +0.6% | +$3.54K | 0.02% | 728 |
|
|
2025
Q2 | $554K | Buy |
2,295
+746
| +48% | +$176K | 0.02% | 805 |
|
|
2025
Q1 | $377K | Buy |
1,549
+1,500
| +3,061% | +$451K | 0.01% | 934 |
|
|
2024
Q4 | $16.1K | Buy |
49
+20
| +69% | +$6.79K | ﹤0.01% | 1977 |
|
|
2024
Q3 | $9.7K | Buy |
29
+4
| +16% | +$1.27K | ﹤0.01% | 2153 |
|
|
2024
Q2 | $6.83K | Sell |
25
-101
| -80% | -$29.4K | ﹤0.01% | 2222 |
|
|
2024
Q1 | $43.6K | Buy |
126
+51
| +68% | +$16.8K | ﹤0.01% | 1473 |
|
|
2023
Q4 | $24.2K | Buy |
75
+45
| +150% | +$14.1K | ﹤0.01% | 1727 |
|
|
2023
Q3 | $10.8K | Sell |
30
-14
| -32% | -$5.4K | ﹤0.01% | 1966 |
|
|
2023
Q2 | $16.7K | Sell |
44
-137
| -76% | -$55.8K | ﹤0.01% | 1804 |
|
|
2023
Q1 | $86.7K | Buy |
181
+35
| +24% | +$16.4K | 0.01% | 921 |
|
|
2022
Q4 | $61.4K | Buy |
146
+61
| +72% | +$24.6K | 0.01% | 1049 |
|
|
2022
Q3 | $35K | Sell |
85
-65
| -43% | -$32.4K | ﹤0.01% | 1233 |
|
|
2022
Q2 | $74K | Sell |
150
-4
| -3% | -$2.08K | 0.01% | 750 |
|
|
2022
Q1 | $87K | Hold |
154
| – | – | 0.01% | 726 |
|
|
2021
Q4 | $116K | Buy |
154
+12
| +8% | +$8.98K | 0.01% | 604 |
|
|
2021
Q3 | $106K | Buy |
142
+8
| +6% | +$5.99K | 0.01% | 601 |
|
|
2021
Q2 | $86K | Sell |
134
-2
| -1% | -$1.22K | 0.01% | 655 |
|
|
2021
Q1 | $78K | Buy |
136
+9
| +7% | +$5.33K | 0.01% | 664 |
|
|
2020
Q4 | $74K | Sell |
127
-4
| -3% | -$2.28K | 0.01% | 606 |
|
|
2020
Q3 | $68K | Buy |
131
+68
| +108% | +$34.4K | 0.01% | 552 |
|
|
2020
Q2 | $28K | Sell |
63
-229
| -78% | -$101K | 0.01% | 926 |
|
|
2020
Q1 | $103K | Buy |
292
+19
| +7% | +$6.99K | 0.02% | 572 |
|
|
2019
Q4 | $96K | Hold |
273
| – | – | 0.01% | 999 |
|
|
2019
Q3 | $87K | Buy |
273
+169
| +163% | +$55.1K | 0.01% | 946 |
|
|
2019
Q2 | $29K | Hold |
104
| – | – | ﹤0.01% | 1462 |
|
|
2019
Q1 | $29K | Buy |
104
+70
| +206% | +$18.9K | 0.01% | 1402 |
|
|
2018
Q4 | $5K | Buy |
34
+9
| +36% | +$2.42K | ﹤0.01% | 1625 |
|
|
2018
Q3 | $6K | Hold |
25
| – | – | ﹤0.01% | 1477 |
|
|
2018
Q2 | $6K | Hold |
25
| – | – | ﹤0.01% | 1481 |
|
|
2018
Q1 | $6K | Hold |
25
| – | – | ﹤0.01% | 1455 |
|
|
2017
Q4 | $3K | Hold |
25
| – | – | ﹤0.01% | 1626 |
|
|
2017
Q3 | $3K | Buy |
25
+8
| +47% | +$1.8K | ﹤0.01% | 1619 |
|
|
2017
Q2 | $1K | Hold |
17
| – | – | ﹤0.01% | 1701 |
|
|
2017
Q1 | $2K | Buy |
17
+4
| +31% | +$770 | ﹤0.01% | 1571 |
|
|
2016
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 1639 |
|
|
2016
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 1622 |
|
|
2016
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 1592 |
|
|
2016
Q1 | $1K | Buy |
13
+3
| +30% | +$394 | ﹤0.01% | 1458 |
|
|
2015
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 1420 |
|
|
2015
Q3 | $1K | Buy |
10
+5
| +100% | +$720 | ﹤0.01% | 1048 |
|
|
2015
Q2 | $0 | Buy |
+5
| New | +$715 | ﹤0.01% | 1234 |
|
Other funds holding BIO
VCM
VPM
AI
